ClinicaSpace.com
Clinical Research
News & Careers
 
Search the Site
    
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login


By Industry | By Industry Segment | By Services and Suppliers | By Location | Profile Search
 Company Profile

 

Amgen 

Corporate Headquarters
One Amgen Center Drive
Thousand Oaks  California  91320-1789  U.S.A.
Phone: 805-447-1000 Fax: 805-447-1010


SEARCH JOBS




Collaborations

Genesis Research and Development Corporation 

Phylos, Inc.  In 2000, Phylos entered into collaboration with Amgen to apply Phylos' PROfusion™ technology to rapidly identify high-affinity binding agents to potential therapeutic targets supplied by Amgen. Amgen will use the sequences and structural information gained through this collaboration for its internal drug discovery programs.

UCB, Inc.  Contract manufacturing of Abarelix peptide active ingredient

EPIX Pharmaceuticals, Inc. 

Dyax Corp.  Antibody phage display





 Company News
Amgen (AMGN) to Present at the UBS Global Life Sciences Conference 5/17/2013 6:40:03 AM    More...
Amgen (AMGN) Release: New Analyses Identify Predictive Biomarkers for Vectibix® (Panitumumab) in Patients With Metastatic Colorectal Cancer 5/16/2013 10:02:07 AM    More...
Atlas Venture Leans on Amgen (AMGN), Novartis AG (NVS) to Build New Startups 5/16/2013 8:13:56 AM    More...
Amgen (AMGN) Highlights Data to be Presented at American Society of Clinical Oncology Annual Meeting 5/16/2013 6:53:46 AM    More...
Amgen (AMGN)'s New JV Fulfills Promise to Emphasize China 5/15/2013 3:13:03 PM    More...
Amgen (AMGN), Hospira, Inc. (HSP) and Sandoz, Inc. Named Among Top Pharmaceutical Companies With Greatest Biosimilar Drug Potential in United States 5/14/2013 12:07:05 PM    More...
Amgen (AMGN) Takes a Stab in China and Forms Pact With Zhejiang Beta Pharma Co. 5/10/2013 8:05:08 AM    More...
Amgen (AMGN) Late-Stage Trial of Colon Cancer Drug Meets Goal 5/8/2013 6:41:09 AM    More...
Another Biosimilar Legislative Defeat for Amgen (AMGN) & Genentech (RHHBY) 5/7/2013 7:47:32 AM    More...
Transgenomic, Inc. (TBIO) Teams Up With Amgen (AMGN) to Develop CE-IVD Test 5/6/2013 7:18:04 AM    More...
12345678910...